Joost A.P. Rens

763 total citations
15 papers, 596 citations indexed

About

Joost A.P. Rens is a scholar working on Molecular Biology, Immunology and Immunology and Allergy. According to data from OpenAlex, Joost A.P. Rens has authored 15 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Immunology and Allergy. Recurrent topics in Joost A.P. Rens's work include Angiogenesis and VEGF in Cancer (6 papers), Cell Adhesion Molecules Research (6 papers) and Phagocytosis and Immune Regulation (3 papers). Joost A.P. Rens is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), Cell Adhesion Molecules Research (6 papers) and Phagocytosis and Immune Regulation (3 papers). Joost A.P. Rens collaborates with scholars based in Netherlands, France and United States. Joost A.P. Rens's co-authors include Timo L.M. ten Hagen, Alexander M.M. Eggermont, Remco van Horssen, Jacob A. Aten, Hence J.M. Verhagen, Berina Eppink, Przemek M. Krawczyk, Roland Kanaar, Hanny Odijk and Mark J. O’Connor and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Joost A.P. Rens

15 papers receiving 589 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Joost A.P. Rens 266 197 148 94 91 15 596
G. Kesava Reddy 254 1.0× 116 0.6× 234 1.6× 76 0.8× 56 0.6× 55 693
Raphael Reuten 153 0.6× 125 0.6× 124 0.8× 96 1.0× 43 0.5× 24 486
Lele Zhang 231 0.9× 143 0.7× 244 1.6× 132 1.4× 111 1.2× 13 632
RK Jain 155 0.6× 124 0.6× 99 0.7× 53 0.6× 97 1.1× 38 589
Renske J.E. van den Bijgaart 149 0.6× 210 1.1× 223 1.5× 145 1.5× 58 0.6× 19 575
Valérie Rouffiac 302 1.1× 189 1.0× 190 1.3× 38 0.4× 182 2.0× 31 694
Julia Bar 207 0.8× 93 0.5× 135 0.9× 48 0.5× 77 0.8× 46 524
Klemens Löster 425 1.6× 110 0.6× 193 1.3× 78 0.8× 116 1.3× 39 918
Ryan J. Osgood 251 0.9× 90 0.5× 291 2.0× 84 0.9× 91 1.0× 13 591
Sabrina Kellouche 231 0.9× 109 0.6× 145 1.0× 78 0.8× 69 0.8× 28 549

Countries citing papers authored by Joost A.P. Rens

Since Specialization
Citations

This map shows the geographic impact of Joost A.P. Rens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joost A.P. Rens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joost A.P. Rens more than expected).

Fields of papers citing papers by Joost A.P. Rens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joost A.P. Rens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joost A.P. Rens. The network helps show where Joost A.P. Rens may publish in the future.

Co-authorship network of co-authors of Joost A.P. Rens

This figure shows the co-authorship network connecting the top 25 collaborators of Joost A.P. Rens. A scholar is included among the top collaborators of Joost A.P. Rens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joost A.P. Rens. Joost A.P. Rens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Voets, Erik, Marc Paradé, D. Lutje Hulsik, et al.. (2019). Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint. Journal for ImmunoTherapy of Cancer. 7(1). 340–340. 56 indexed citations
2.
Voets, Erik, Joost H. C. M. Kreijtz, Paul Vink, et al.. (2019). Abstract 1203: Preclinical development of ADU-1805, a highly selective pan-allele anti-SIRPα antibody that blocks the SIRPα-CD47 innate immune checkpoint. Cancer Research. 79(13_Supplement). 1203–1203. 1 indexed citations
3.
Das, Asha, Michiel Bolkestein, Joost A.P. Rens, et al.. (2016). Tissue inhibitor of metalloproteinase-3 (TIMP3) expression decreases during melanoma progression and inhibits melanoma cell migration. European Journal of Cancer. 66. 34–46. 23 indexed citations
4.
Brakel, Mandy van, Sara Zalba, Erik van Schooten, et al.. (2016). Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody. International Journal of Nanomedicine. 11. 955–955. 30 indexed citations
5.
Das, Asha, Mario Pescatori, Joost A.P. Rens, et al.. (2016). Melanomas prevent endothelial cell death under restrictive culture conditions by signaling through AKT and p38 MAPK/ ERK-1/2 cascades. OncoImmunology. 5(10). e1219826–e1219826. 8 indexed citations
6.
Das, Asha, Ann L.B. Seynhaeve, Joost A.P. Rens, et al.. (2013). Differential TIMP3 expression affects tumor progression and angiogenesis in melanomas through regulation of directionally persistent endothelial cell migration. Angiogenesis. 17(1). 163–177. 36 indexed citations
7.
Seynhaeve, Ann L.B., Joost A.P. Rens, Debby Schipper, Alexander Eggermont, & Timo L.M. ten Hagen. (2013). Exposing endothelial cells to tumor necrosis factor-α and peripheral blood mononuclear cells damage endothelial integrity via interleukin-1ß by degradation of vascular endothelial-cadherin. Surgery. 155(3). 545–553. 12 indexed citations
8.
Horssen, Remco van, Antoinette Hollestelle, Joost A.P. Rens, et al.. (2012). E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells. Breast Cancer Research and Treatment. 136(2). 365–377. 24 indexed citations
9.
Cheng, Caroline, Remco Haasdijk, Dennie Tempel, et al.. (2012). PDGF-Induced Migration of Vascular Smooth Muscle Cells Is Inhibited by Heme Oxygenase-1 Via VEGFR2 Upregulation and Subsequent Assembly of Inactive VEGFR2/PDGFRβ Heterodimers. Arteriosclerosis Thrombosis and Vascular Biology. 32(5). 1289–1298. 26 indexed citations
10.
Krawczyk, Przemek M., Berina Eppink, Jeroen Essers, et al.. (2011). Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition. Proceedings of the National Academy of Sciences. 108(24). 9851–9856. 276 indexed citations
11.
Brunstein, Flávia, et al.. (2006). Synergistic Antitumor Effects of Histamine Plus Melphalan in Isolated Hepatic Perfusion for Liver Metastases. Annals of Surgical Oncology. 14(2). 795–801. 9 indexed citations
12.
Brunstein, Flávia, Joost A.P. Rens, Sandra T. van Tiel, Alexander M.M. Eggermont, & Timo L.M. ten Hagen. (2006). Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery. British Journal of Cancer. 95(12). 1663–1669. 14 indexed citations
13.
Horssen, Remco van, et al.. (2006). Intratumoural expression of TNF‐R1 and EMAP‐II in relation to response of patients treated with TNF‐based isolated limb perfusion. International Journal of Cancer. 119(6). 1481–1490. 12 indexed citations
14.
Horssen, Remco van, Joost A.P. Rens, Debby Schipper, Alexander M.M. Eggermont, & Timo L.M. ten Hagen. (2006). EMAP-II facilitates TNF-R1 apoptotic signalling in endothelial cells and induces TRADD mobilization. APOPTOSIS. 11(12). 2137–2145. 18 indexed citations
15.
Horssen, Remco van, Niels Galjart, Joost A.P. Rens, Alexander M.M. Eggermont, & Timo L.M. ten Hagen. (2006). Differential effects of matrix and growth factors on endothelial and fibroblast motility: Application of a modified cell migration assay. Journal of Cellular Biochemistry. 99(6). 1536–1552. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Kesava Reddy Breakdown of academic impact, for papers by Raphael Reuten Breakdown of academic impact, for papers by Lele Zhang Breakdown of academic impact, for papers by RK Jain Breakdown of academic impact, for papers by Renske J.E. van den Bijgaart Breakdown of academic impact, for papers by Valérie Rouffiac Breakdown of academic impact, for papers by Julia Bar Breakdown of academic impact, for papers by Klemens Löster Breakdown of academic impact, for papers by Ryan J. Osgood Breakdown of academic impact, for papers by Sabrina Kellouche
Rankless by CCL
2026